tci Medicare Compliance & Reimbursement - 2009 Issue 9
INDUSTRY NOTES: Off-Kilter Claim Patterns for Inhalation Drugs Set Off OIG's Radar in South Florida
Subscribe or sign in to view the full article.
Article Overview
This industry note covers a Medicare program integrity issue highlighted by the OIG in South Florida, where inhalation drug claims drew disproportionate spending attention. It is relevant to compliance, billing oversight, and suppliers or providers involved with inhalation drug claims and DME-related Medicare reimbursement. The article provides a brief summary of the report’s findings and the general oversight response being urged.
Why This Topic Matters
The piece signals a Medicare fraud- and abuse-risk area that may attract contractor scrutiny and policy enforcement attention, especially for organizations handling inhalation drug claims in South Florida or similar high-volume billing environments.
What You Will Learn
- Why South Florida inhalation drug claims drew OIG attention
- What kinds of Medicare oversight concerns were raised
- How the report connects claim patterns to broader program integrity review
- Why DME suppliers and contractors may be affected by the findings
Who Should Read This
- Medical coders
- Billing specialists
- Compliance officers
- Healthcare auditors
- DME suppliers
- Physician practice managers
- Revenue cycle teams
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com